1. Home
  2. GKOS vs ZETA Comparison

GKOS vs ZETA Comparison

Compare GKOS & ZETA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • ZETA
  • Stock Information
  • Founded
  • GKOS 1998
  • ZETA 2007
  • Country
  • GKOS United States
  • ZETA United States
  • Employees
  • GKOS N/A
  • ZETA N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • ZETA EDP Services
  • Sector
  • GKOS Health Care
  • ZETA Technology
  • Exchange
  • GKOS Nasdaq
  • ZETA Nasdaq
  • Market Cap
  • GKOS 5.1B
  • ZETA 5.0B
  • IPO Year
  • GKOS 2015
  • ZETA 2021
  • Fundamental
  • Price
  • GKOS $94.31
  • ZETA $13.13
  • Analyst Decision
  • GKOS Strong Buy
  • ZETA Strong Buy
  • Analyst Count
  • GKOS 13
  • ZETA 14
  • Target Price
  • GKOS $135.15
  • ZETA $29.23
  • AVG Volume (30 Days)
  • GKOS 914.5K
  • ZETA 3.9M
  • Earning Date
  • GKOS 04-30-2025
  • ZETA 05-01-2025
  • Dividend Yield
  • GKOS N/A
  • ZETA N/A
  • EPS Growth
  • GKOS N/A
  • ZETA N/A
  • EPS
  • GKOS N/A
  • ZETA N/A
  • Revenue
  • GKOS $404,523,000.00
  • ZETA $1,075,226,000.00
  • Revenue This Year
  • GKOS $27.89
  • ZETA $25.78
  • Revenue Next Year
  • GKOS $27.57
  • ZETA $17.31
  • P/E Ratio
  • GKOS N/A
  • ZETA N/A
  • Revenue Growth
  • GKOS 23.92
  • ZETA 40.36
  • 52 Week Low
  • GKOS $77.10
  • ZETA $10.69
  • 52 Week High
  • GKOS $163.71
  • ZETA $38.20
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 50.08
  • ZETA 46.04
  • Support Level
  • GKOS $93.52
  • ZETA $12.80
  • Resistance Level
  • GKOS $101.57
  • ZETA $13.73
  • Average True Range (ATR)
  • GKOS 3.33
  • ZETA 0.55
  • MACD
  • GKOS 0.40
  • ZETA -0.07
  • Stochastic Oscillator
  • GKOS 42.24
  • ZETA 14.41

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About ZETA Zeta Global Holdings Corp.

Zeta Global Holdings Corp is an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software. It serves enterprise customers across multiple industries, including financial services, insurance, telecommunications, automotive, travel and hospitality, and retail. Its Zeta Marketing Platform, or ZMP, is an omnichannel marketing platform with identity data at its core. The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry's opted-in data set for omnichannel marketing.

Share on Social Networks: